KOLYSE CAVER: Open Payments
NPI 1891338703 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,149 in 147 payments from 29 companies in 2025. Trend: 2023 $4,213 · 2024 $3,604 · 2025 $3,149
Food & beverage: $3,067Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $562 |
| PFIZER INC. | 15 | $326 |
| Alexion Pharmaceuticals, Inc. | 8 | $209 |
| Lundbeck LLC | 8 | $201 |
| Teva Pharmaceuticals USA, Inc. | 7 | $199 |
| Lilly USA, LLC | 9 | $154 |
| Biogen, Inc. | 7 | $152 |
| EMD Serono, Inc. | 6 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
Products named: NURTEC ODT, QULIPTA, ULTOMIRIS, VYEPTI, UBRELVY, LEQEMBI, REXULTI, KISUNLA.
Industry payments across GA — which companies pay providers there.
